Cargando…
Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars
INTRODUCTION: Scarring is an unfortunate clinical outcome of acne. Current treatment options for atrophic acne scars are dominated by non-pharmacological, invasive procedures which may not be suitable or affordable to all patients. This phase II, single-center, open-label, exploratory study assessed...
Autores principales: | Loss, Manisha J., Leung, Sherry, Chien, Anna, Kerrouche, Nabil, Fischer, Alexander H., Kang, Sewon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002315/ https://www.ncbi.nlm.nih.gov/pubmed/29549598 http://dx.doi.org/10.1007/s13555-018-0231-8 |
Ejemplares similares
-
Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison
por: Dréno, Brigitte, et al.
Publicado: (2018) -
Development of Adapalene Loaded Liposome Based Gel for Acne
por: Arooj, Asma, et al.
Publicado: (2023) -
New Patient-Oriented Tools for Assessing Atrophic Acne Scarring
por: Layton, Alison, et al.
Publicado: (2016) -
Atrophic acne scars, including scars less than 1.5 mm, may undergo spontaneous regression: A cohort study
por: Balagula, Yevgeniy, et al.
Publicado: (2023) -
Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study
por: Myhill, Timothy, et al.
Publicado: (2017)